Acute oxalate nephropathy associated with orlistat
Background: Obesity is a major world-wide epidemic which has led to a surge of various weight loss-inducing medical or surgical treatments. Orlistat is a gastrointestinal lipase inhibitor used as an adjunct treatment of obesity and type 2 diabetes mellitus to induce clinically significant weight lo...
| Main Authors: | , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Society of Diabetic Nephropathy Prevention
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844913/ |